Novel Agents and Combinations in Hodgkin Lymphoma
0 المشاهدات
• 07/09/23
0
0
تضمين
administrator
مشتركين
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
أظهر المزيد
تعليقات الفيسبوك
SORT BY-
أعلى تعليقات
-
أحدث تعليقات